UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Leukemia & lymphoma, ISSN 1042-8194, 6/2011, Volume 52, Issue 6, pp. 1098 - 1107
mean fluorescence intensity (MFI) | monoclonal antibody therapy | antigen expression | antibody binding capacity (ABC) | Acute lymphoid leukemia (ALL) | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Antigens, CD - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Flow Cytometry - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Middle Aged | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Sialic Acid Binding Ig-like Lectin 2 - immunology | Antigens, CD - metabolism | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Sialic Acid Binding Ig-like Lectin 2 - metabolism | Aged, 80 and over | Adult | Transcription, Genetic | Sialic Acid Binding Ig-like Lectin 3 | Child | Antibodies, Monoclonal - immunology | Antigens, Differentiation, Myelomonocytic - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antigens, CD19 - immunology | Antigens, CD20 - immunology | Immunophenotyping | Antigens, CD20 - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Reverse Transcriptase Polymerase Chain Reaction | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Oncogene Proteins, Fusion - genetics | Antigens, Differentiation, Myelomonocytic - metabolism | Adolescent | Aged | Antigens, CD19 - metabolism | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. e205 - e217
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Recurrence | Immunotherapy - methods | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Salvage Therapy | Child, Preschool | Drug Resistance, Neoplasm | Infant | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Time Factors | Drug Design | Adult | Female | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | Risk Assessment | Risk Factors | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Adolescent | Age of Onset | Monoclonal antibodies | Relapse | Drug resistance | Immunotherapy | Diseases | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 10/2014, Volume 514, Issue 7523, pp. 513 - 517
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Tumor Suppressor Proteins - metabolism | Histones - chemistry | Benzazepines - pharmacology | Pyrimidines - pharmacology | Histone Demethylases - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Histone Demethylases - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Animals | Methylation - drug effects | Jumonji Domain-Containing Histone Demethylases - antagonists & inhibitors | Tumor Suppressor Proteins - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - enzymology | Epigenesis, Genetic - drug effects | Lysine - metabolism | Mice | Histones - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Jumonji Domain-Containing Histone Demethylases - metabolism | Histones | Genetic aspects | Lymphocytic leukemia | Methyltransferases | Lysine | Health aspects | Studies | Proteins | Genomes | Genes | Leukemia | Binding sites | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1005 - 1015
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Adolescents | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2020, Volume 135, Issue 11, pp. 804 - 813
Life Sciences & Biomedicine | Hematology | Science & Technology | Antineoplastic Agents, Immunological - administration & dosage | Recurrence | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - etiology | Humans | Middle Aged | Male | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Adult | Female | Lymphoma, B-Cell - etiology | Molecular Targeted Therapy - methods | Receptors, Chimeric Antigen - metabolism | Antigens, CD19 - immunology | Lymphoma, B-Cell - drug therapy | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Receptors, Antigen, T-Cell - metabolism | Treatment Outcome | Combined Modality Therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Immunological - therapeutic use | Lymphoma, B-Cell - pathology | Receptors, Chimeric Antigen - genetics | Aged | Receptors, Antigen, T-Cell - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - etiology | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 19, pp. 3298 - 3307
Life Sciences & Biomedicine | Hematology | Science & Technology | GATA3 Transcription Factor - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Age Factors | Exons | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Genetic Loci | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Female | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | B-Lymphocytes - metabolism | Genetic Predisposition to Disease | Genome-Wide Association Study | Introns | Phosphotransferases (Alcohol Group Acceptor) - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Phenotype | Alleles | Survival Analysis | Polymorphism, Single Nucleotide | Chromosomes, Human, Pair 10 | Index Medicus | Abridged Index Medicus | Clinical Medicine | Hematologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 26, pp. 6226 - 6233
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Immunotherapy - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Antibodies, Bispecific - pharmacokinetics | Antilymphocyte Serum - metabolism | Antilymphocyte Serum - administration & dosage | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology | Immunologic Factors - pharmacokinetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | T-Lymphocytes - drug effects | Antibodies, Bispecific - administration & dosage | Adult | Cytotoxicity, Immunologic - drug effects | Antigens, CD19 - immunology | Antilymphocyte Serum - adverse effects | Infusion Pumps | Immunologic Factors - administration & dosage | Treatment Outcome | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Immunotherapy - adverse effects | Antibodies, Bispecific - adverse effects | Lymphocyte Activation - drug effects | Immune System - drug effects | CD3 Complex - immunology | T-Lymphocytes - immunology | Immunologic Factors - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 05/2015, Volume 521, Issue 7552, pp. 357 - 361
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Protein-Tyrosine Kinases - metabolism | Receptors, Antigen, B-Cell - deficiency | Humans | Precursor Cells, B-Lymphoid - metabolism | Inositol Polyphosphate 5-Phosphatases | Intracellular Signaling Peptides and Proteins - metabolism | Precursor Cells, B-Lymphoid - drug effects | Receptors, Antigen, B-Cell - metabolism | Antigens, CD - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor Cells, B-Lymphoid - pathology | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Gene Deletion | Female | B-Lymphocytes - pathology | Cell Death - drug effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Syk Kinase | B-Lymphocytes - metabolism | Disease Models, Animal | Phosphoric Monoester Hydrolases - antagonists & inhibitors | Enzyme Activation - drug effects | Mice, SCID | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Xenograft Model Antitumor Assays | B-Lymphocytes - drug effects | Fusion Proteins, bcr-abl - genetics | Tyrosine - metabolism | Animals | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - metabolism | Signal Transduction - drug effects | Cell Transformation, Neoplastic | Intracellular Signaling Peptides and Proteins - agonists | Cell Line, Tumor | Mice, Inbred NOD | Receptors, Antigen, B-Cell - genetics | Mice | Amino Acid Motifs - genetics | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | Phosphoric Monoester Hydrolases - metabolism | Receptors, Immunologic - genetics | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - deficiency | Receptors, Immunologic - metabolism | Drug Resistance, Neoplasm - drug effects | Physiological aspects | Acute lymphocytic leukemia | B cells | Signal transduction | Rodents | Leukemia | Mutation | Drug resistance | Kinases | Cells | Index Medicus
Journal Article